Literature DB >> 26595491

Relationship Between the Neutrophil to Lymphocyte Ratio and Parathyroid Adenoma Size in Patients With Primary Hyperparathyroidism.

Sezgin Zeren1, Faik Yaylak1, Isa Ozbay2, Zulfu Bayhan1.   

Abstract

The aim of our study was to evaluate the relationship between neutrophil to lymphocyte ratio (NLR) and adenoma size in parathyroidectomized patients who underwent a parathyroidectomy. The neutrophil to lymphocyte ratio has recently become popular as a biomarker for malignant diseases or for estimating tumor size preoperatively. This study aimed to estimate the relationship between adenoma size and NLR. Furthermore, we assessed whether a higher level of NLR is correlated with the presence of parathyroid carcinoma. A retrospective chart review was performed for patients with parathyroid adenoma who underwent parathyroidectomy between January 2012 and August 2014. Data related to age, sex, NLR, parathyroid hormone level (PTH), preoperative calcium, phosphorus, adenoma size, and pathology reports were collected. The neutrophil to lymphocyte ratio was significantly correlated with calcium levels, PTH levels, parathyroid adenoma size, and the presence of cancer. However, there was no correlation between NLR and age, sex, and phosphorus levels. This study is the first to document a positive correlation between NLR and parathyroid adenoma size, as well as the presence of cancer, in patients who underwent surgery as a result of primary hyperparathyroidism.

Entities:  

Keywords:  Lymphocyte; Neutrophil; Parathyroid adenoma; Primary hyperparathyroidism

Mesh:

Year:  2015        PMID: 26595491     DOI: 10.9738/INTSURG-D-15-00044.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  8 in total

Review 1.  Primary hyperparathyroidism-related giant parathyroid adenoma (Review).

Authors:  Adina Ghemigian; Alexandra Ioana Trandafir; Eugenia Petrova; Mara Carsote; Ana Valea; Alexandru Filipescu; Ana-Maria Oproiu; Florica Sandru
Journal:  Exp Ther Med       Date:  2021-11-26       Impact factor: 2.447

Review 2.  Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.

Authors:  Romans Uljanovs; Stanislavs Sinkarevs; Boriss Strumfs; Liga Vidusa; Kristine Merkurjeva; Ilze Strumfa
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

3.  IS THERE A RELATIONSHIP BETWEEN PARATHYROID HORMONE AND NEUTROPHIL LYMPHOCYTE RATIO OR PLATELET LYMPHOCYTE RATIO?

Authors:  A Toraman; F Aras; Z Hekimsoy; S Kursat
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

4.  Association between neutrophil-to-lymphocyte ratio and parathyroid hormone in patients with primary hyperparathyroidism.

Authors:  Hung-Bun Lam; Po-Sheng Yang; Ming-Nan Chien; Jie-Jen Lee; Li-Fen Chao; Shih-Ping Cheng
Journal:  Arch Med Sci       Date:  2018-03-28       Impact factor: 3.318

5.  Role of neutrophil extracellular traps in regulation of lung cancer invasion and metastasis: Structural insights from a computational model.

Authors:  Junho Lee; Donggu Lee; Sean Lawler; Yangjin Kim
Journal:  PLoS Comput Biol       Date:  2021-02-17       Impact factor: 4.475

6.  Preoperative inflammatory markers for predicting parathyroid carcinoma.

Authors:  Keiko Ohkuwa; Kiminori Sugino; Ryohei Katoh; Mitsuji Nagahama; Wataru Kitagawa; Kenichi Matsuzu; Akifumi Suzuki; Chisato Tomoda; Kiyomi Hames; Junko Akaishi; Chie Masaki; Kana Yoshioka; Koichi Ito
Journal:  Endocr Connect       Date:  2022-07-14       Impact factor: 3.221

7.  Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model.

Authors:  Yangjin Kim; Donggu Lee; Junho Lee; Seongwon Lee; Sean Lawler
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

Review 8.  Serum Inflammation-based Scores in Endocrine Tumors.

Authors:  Pedro Marques; Friso de Vries; Olaf M Dekkers; Márta Korbonits; Nienke R Biermasz; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.